Abstract:In the current study, chromatographic and in silico techniques were applied to investigate the biotransformation of ethyl 5-(4-bromophenyl)-1-(2-(2-(2-hydroxybenzylidene) hydrazinyl)-2-oxoethyl)-2-methyl-1H-pyrrole-3-carboxylate (11b) in hepatocytic media. The initial chromatographic procedure was based on the employment of the conventional octadecyl stationary phase method for estimation of the chemical stability. Subsequently, a novel and rapid chromatographic approach based on a phenyl–hexyl column was developed, aiming to separate the possible metabolites. Both methods were performed on a Dionex 3000 ThermoScientific (ACM 2, Sofia, Bulgaria) device equipped with a diode array detector set up at 272 and 279 nm for analytes detection. An acetonitrile: phosphate buffer of pH 3.5: methanol (17:30:53 v/v/v) was eluted isocratically as a mobile phase with a 1 mL/min flow rate. A preliminary purification from the biological media was achieved by protein precipitation with methanol. A validation procedure was carried out, where the method was found to correspond to all ICH (Q2) and M10 set criteria. Additionally, an in silico-based approach with the online server BioTransformer 3.0 was applied in an attempt to predict the possible metabolites of the title compound 11b. It was hypothesized that four CYP450 isoforms (1A2, 2C9, 3A4, and 2C8) were involved in the phase I metabolism, resulting in the formation of 12 metabolites. Moreover, docking studies were conducted to evaluate the formation of stable complexes between 11b and the aforementioned isoforms. The obtained data indicated three metabolites as the most probable products, two of which (M9_11b and M10_11b) were synthesized by a classical approach for verification. Finally, liquid chromatography with a mass detector was implemented for comprehensive and summarized analysis, and the obtained results revealed that the metabolism of the 11b proceeds possibly with the formation of glucuronide and glycine conjugate of M11_11b.

Development of Hyphenated Techniques and Network Identification Approaches for Biotransformational Evaluation of Promising Antitubercular N-pyrrolyl hydrazide-hydrazone in Isolated Rat Hepatocytes

In Silico and Chromatographic Methods for Analysis of Biotransformation of Prospective Neuroprotective Pyrrole-Based Hydrazone in Isolated Rat Hepatocytes

RP-HPLC DETERMINATION OF DIPHENYTRIAZOL IN RAT LIVER MICROSOMAL INCUBATES AND ITS APPLICATION IN IN VITRO METABOLISM

Precision Biotransformation of Emerging Pollutants by Human Cytochrome P450 Using Computational–Experimental Synergy: A Case Study of Tris(1,3-dichloro-2-propyl) Phosphate

Liquid Chromatography/Quadrupole Time-Of-Flight Mass Spectrometry in Combination with Online Hydrogen/Deuterium Exchange Technique for Structural Elucidation of Phase I Metabolites of Iso-Phenylcyclopentylamine in Rat Bile

The Profiling of the Metabolites of Hirsutine in Rat by Ultra-High Performance Liquid Chromatography Coupled with Linear Ion Trap Orbitrap Mass Spectrometry: an Improved Strategy for the Systematic Screening and Identification of Metabolites in Multi-Samples in Vivo

Metabolism characterization and toxicity of N-hydap, a marine candidate drug for lung cancer therapy by LC–MS method

Recycling Preparative Isolation of Six Bicyclol Active Metabolites from SD Rat Urine Using Macroporous Resin, Offline 2D LPLC/HPLC, and Prep-Hplc Combined with Pharmacodynamic Evaluation of Two Active Metabolites

Identification of Metabolites of Isopropyl 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate in Rats by High Performance Liquid Chromatography Combined with Electrospray Ionization Quadrupole Time-of-flight Tandem Mass Spectrometry.

Development and validation of an HPLC-DAD method for bis(12)-hupyridone and its application to a pharmacokinetic study.

Rapid and Accurate Liquid Chromatography and Tandem Mass Spectrometry Method for the Simultaneous Quantification of Ten Metabolic Reactions Catalyzed by Hepatic Cytochrome P450 Enzymes.

A High-Throughput Inhibition Screening Of Major Human Cytochrome P450 Enzymes Using An In Vitro Cocktail And Liquid Chromatography-Tandem Mass Spectrometry

Rapid Identification of Phase I and Ii Metabolites of Artemisinin Antimalarials Using Ltq-Orbitrap Hybrid Mass Spectrometer in Combination with Online Hydrogen/Deuterium Exchange Technique

Identification of in vitro and in vivo potential metabolites of novel cardiovascular and adrenolytic drugs by liquid chromatography-mass spectrometry with the aid of experimental design

Evaluation of the Effect of TM208 on the Activity of Five Cytochrome P450 Enzymes Using On-Line Solid-Phase Extraction HPLC–DAD: A Cocktail Approach

Profiling and Identification of Metabolites of Isorhynchophylline in Rats by Ultra High Performance Liquid Chromatography and Linear Ion Trap Orbitrap Mass Spectrometry.

Rapid Identification of Berberine Metabolites in Rat Plasma by UHPLC-Q-TOF-MS

Metabolite identification of triptolide by data-dependent accurate mass spectrometric analysis in combination with online hydrogen/deuterium exchange and multiple data-mining techniques.

Development and validation for bioanalysis of VK2809, its active metabolite VK2809A and glutathione-conjugated metabolite MB06588 in rat liver using LC-MS/MS

Biotransformation of Isoimperatorin by Rat Liver Microsomes and Its Quantification by Lc-Ms/Ms Method

Combination of UHPLC/Q-TOF-MS, NMR Spectroscopy, and ECD Calculation for Screening and Identification of Reactive Metabolites of Gentiopicroside in Humans